WINNIPEG, MANITOBA--(Marketwire - Sept. 3, 2008) - Medicure Inc.

Medicure Inc. (TSX: MPH), a cardiovascular-focused biopharmaceutical company, today provided an update on its cash position and commercial operations.

Medicure Inc.

Medicure Inc.

Medicure Inc. (TSX: MPH)(AMEX: MCU), a cardiovascular-focused biopharmaceutical company, today announced the presentation of its Phase 3 MEND-CABG II study results at the American College of Cardiology 57th Annual Scientific Session.